Management of anterior mediastinal masses in children

C L Garey1, C A Laituri, P A Valusek

  • 1Department of Surgery, Children's Mercy Hospital, Kansas City 64108, United States.

Insights

Anterior mediastinal masses in children pose anesthesia risks. A cautious, multi-disciplinary approach with a contingency plan is crucial for diagnosis and management, improving survival rates.

Area of Science:

  • Pediatric Surgery
  • Thoracic Oncology
  • Anesthesiology

Background:

  • Anterior mediastinal masses in children present significant risks for life-threatening airway compromise during anesthesia.
  • These masses pose diagnostic and management challenges for pediatric surgeons.

Purpose of the Study:

  • To review the diagnosis, management, and outcomes of children with anterior mediastinal masses.
  • To identify predictors of complications and assess the effectiveness of diagnostic strategies.

Main Methods:

  • Retrospective chart review of pediatric patients with anterior mediastinal masses from 1994-2009.
  • Analysis of demographics, clinical findings, radiographic evidence of airway compression, diagnostic studies, diagnoses, and complications.
  • Evaluation of correlation between symptoms, airway obstruction, pulmonary function, and complications.

Main Results:

  • 26 pediatric patients were identified; mean age 11.3 years. Lymphoma (62%) was the most common diagnosis.
  • 62% of patients showed radiographic evidence of airway compression; only 12% had tracheal cross-sectional area <50%.
  • 3 patients experienced anesthesia-related complications; no anesthesia-related deaths occurred. Overall survival was 85%.

Conclusions:

  • A step-wise, multi-disciplinary approach, starting with least invasive techniques, is recommended for managing pediatric anterior mediastinal masses.
  • Surgeons must have a pre-established contingency plan for general anesthesia in these high-risk patients.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...